COVID-19 Impact on Global Atenolol Market

  • On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organization (WHO) declared the Coronavirus disease (COVID-19) outbreak a public health emergency of international concern. Originating in China, the virus has spread to at least 214 countries and territories around the world.
  • Several governments and private sector businesses are operating at a limited capacity or have ceased operations completely due to recent events surrounding the COVID-19 pandemic
  • The outbreak of the COVID-19 pandemic has led to disturbance in the supply chain due to the global lockdown in several countries. Also, the spread of the coronavirus has led to a fall in demand for chemical intermediates due to uncertainty in the global economy and capital markets.
  • The atenolol market has been negatively affected due to the COVID-19 pandemic and nationwide lockdown of several non-essential activities and manufacturing facilities. However, the market is anticipated to expand during the forecast period due to the acceptance of new normal conditions and restart of end-use industries in various countries across the globe.

Key Drivers and Restraints of Atenolol Market

  • Demand for atenolol is expected to increase at a significant pace during the forecast period due to rise in incidence of hypertension across the globe. Increase in geriatric population and sedentary lifestyle is boosting the atenolol market.
  • Rise in awareness about complications associated with hypertension is a major factor that is fueling the atenolol market
  • Atenolol can cause severe allergic reactions. This is expected to negatively affect the atenolol market.

Atenolol Market: Application Segment

  • Based on application, the atenolol market can be divided into hypertension, angina, arrhythmia, and others. Of these, the hypertension segment dominates the atenolol market.
  • Strong demand for antihypertensive drugs in the global market is expected to drive the atenolol demand during the forecast period

Atenolol Market: Distribution Channel Segment

  • In terms of distribution channel, the atenolol market can be segregated into retail pharmacy, hospital pharmacy, and e-commerce. Of these, the hospital pharmacy segment dominates the atenolol market. This can be ascribed to the rise in number of hospitals worldwide.
  • The e-commerce segment is expected to exhibit rapid growth rate during the forecast period, owing to surge in the usage of Internet across the globe

Asia-Pacific to Hold Leading Share of Global Atenolol Market

  • In terms of region, the atenolol market has been split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • Asia Pacific is expected to hold major share of the global atenolol market, followed by North America and Europe, during the forecast period
  • According to the World Health Organization, 1.13 billion individuals worldwide had hypertension in 2018, of which two-third resided in low income and developing countries. Over the past decade, the global burden of hypertension has increased, primarily driven by a significant rise in population, lifestyle changes, and increase in the geriatric population worldwide. In the current scenario, hypertension is effectively controlled in less than 20% of the patients across the world, which means there is a mounting demand for antihypertensive drugs, particularly in developing regions.
  • The market in Asia Pacific is projected to expand at a rapid pace during the forecast period, owing to surge in awareness related to the use of antihypertensive drugs. Furthermore, the constantly evolving life science industry is driving the growth of the market in developing economies such as India, China, and Malaysia.

Key Manufacturers Operating in Global Atenolol Market

The atenolol market was consolidated in 2020. Major players have prominent presence in developed and developing countries. Key manufacturers operating in the atenolol market include:

  • AstraZeneca
  • ACETO
  • Aurobindo Pharma
  • Sandoz
  • Mylan
  • Sun Pharmaceutical
  • Teva
  • Zydus Pharmaceuticals
  • Unique Pharmaceuticals
  • Ipca Laboratories
  • Intas Pharmaceuticals

Atenolol Market: Research Scope

Atenolol Market, by Product Type

  • 25mg
  • 50mg
  • 100mg

Atenolol Market, by Application

  • Hypertension
  • Angina
  • Arrhythmia
  • Others

Atenolol Market, by Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • E-commerce

Global Atenolol Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia & CIS
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • ASEAN
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Atenolol Market: Introduction

  • Atenolol is a medication of the beta blockers type. It is used to treat high blood pressure and chest pain. It can also help prevent heart attack; or heart damage after a heart attack.
  • Atenolol is primarily used as an antihypertensive drug. Hypertension is a critical health condition that can lead to cardiovascular diseases, renal failure, stroke, and even death.

This upcoming business intelligence report is intended to be a one-stop market research solution to guide organizations in taking timely and effective decisions for their business growth. The ongoing study is the culmination of our deep expertise on data science methods, combined with an unparalleled understanding of the external environment and analysis of the industries. Each of the reports by TMR aims at offering a detailed scrutiny of the value chain of our current and prospective customers, takes them from identifying value propositions, and subsequently assist their business executives to implement right strategies to create customer value. We believe that creating and sustaining the customer value is the key pivot on which business executives can create profits for their organizations and increase the market shares, continuously and with sustainability.

Each of our touchpoints through which we engage with the organization/enterprise during the primary research enables us to understand the internal environment it operates in and the ways in which the external environment influences its growth.

Always Evolving with Competition

Excellence is built into the DNA of TMR, and all our teams work collaboratively and committedly toward achieving that in whatever they do. From the very first interaction our teams of research analysts have with any interested market participant to the final preparation processes in each of our reports reflects a rigorous understanding of the dynamic industry environment that businesses operate in.

We relentlessly work to be a differentiator in whatever we do in the current era of hypercompetitive global environment. The result of our unceasing focus on excellence is reflected clearly in the insights and guidance we offer to our customers in order to empower them to create brand equity. Our simple yet very powerful underpinning for navigating the competition is to always keep evolving with changing business environments. Our close-kinit team of research analysts not only believe in this simple philosophy but also implement the same.

Constantly Innovating Our Research Methodologies and Models

We do not limit with any specific market research tool or one standard approach for obtaining or analyzing data. Undoubtedly, our report making process is ever-evolving to meet the customer needs and demands supported broadly by a vast knowledge of data science methods that we combine with business acumen our teams have built upon for several years. Evidently, our primary and secondary research data about customers and consumers have shown that we can go to any lengths to obtain them. This is followed by applying next-gen automation tools integrated with human judgement to clear the clutter, ascertain the most relevant and recent qualitative and quantitative insights, and package them in digestible chunks in our reports for our customers.

We Take Pride in No-One-Size-Fits-All Approach

Over the past several years, we have been conducting market intelligence studies across all industries for all types of organizations — big and small, profit and not-for-profit, and Fortune 500 and Unicorns, as we believe that a sound decision making must be based on no-one-size-fits-all approach. Without doubt, each of the organizations regardless of the industry they are in are affected differently by changes in political, economic, socio-culture, legal, ecological, and legal environments. The research models and the value chain analysis process that our analysts employ for conducting the study uphold this approach.

We look at myriad components of internal and external business environment affecting the growth strategies of organizations. Some of the broader aspects that we focus on are:

  • Our team of Analysts and Support Teams always strive to see the bigger picture in life cycle stages of any industry
  • The Teams focus on obtaining valuable insights into different models of competitive advantage while making an internal environment analysis
  • They keep on modifying the value chain analysis processes of organizations to understand on how customer value is created

Some areas of assessing market dynamics that are used in the research models and methodologies adopted by our analysts can be summarized as:

  • Corporate and business strategies underlying new brand positioning strategies
  • Mapping for strategic planning for business units
  • Various metrics for business portfolio analysis, including BCG matrix
  • Value chain analysis

These will help create and sustain competitive advantage for our prospects and current customers.

Key focus areas and agenda that underpin and catalyze our primary and secondary research initiatives and endeavors are:

  • What are some of the core competencies and distinctive competencies of new entrants and established players in the industry we are analyzing?
  • What are some of the branding opportunities that are emerging at a rapid pace?
  • What are the major competitive forces and elements of external environment shaping the industry life cycle stages of most organizations?
  • Why some competitive strategies are popular than others among leaders in a certain market?
  • What customer-based brand equity strategies companies have leveraged in a certain industry or set of related industries in a sector?
  • What are some of the key pricing strategies that companies in an industry are implementing for marketing their products internationally?
  • Identifying whether market-push or market-pull strategies are more relevant to a certain product or a service?

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying